Triethylamine → N-[3(R,S)-5-Cyclohexyl-2,3-dihydro-1-methyl-2--oxo-1H-1,4-benzodiazepin-3-yl]N'-[3-(2-methyltetrazol-5-yl)phenyl]urea
Reaction equation
C1([C:7]2[C:13]3[CH:14]=[CH:15][CH:16]=[CH:17][C:12]=3[N:11]([CH3:18])[C:10](=[O:19])[CH:9]([NH:20][C:21]([O:23]C3C=CC([N+]([O-])=O)=CC=3)=O)[N:8]=2)CCCCC1.C(N([CH2:38][CH3:39])CC)C.[NH2:40][C:41]1[CH:42]=[C:43]([C:47]2[N:48]=[N:49][N:50]([CH3:52])[N:51]=2)[CH:44]=[CH:45][CH:46]=1>CN(C)C=O>[CH2:39]1[CH2:38][CH:7]([C:9]2([NH:20][C:21]([NH:40][C:41]3[CH:46]=[CH:45][CH:44]=[C:43]([C:47]4[N:48]=[N:49][N:50]([CH3:52])[N:51]=4)[CH:42]=3)=[O:23])[N:8]=[CH:7][C:13]3[CH:14]=[CH:15][CH:16]=[CH:17][C:12]=3[N:11]([CH3:18])[C:10]2=[O:19])[CH2:13][CH2:12][CH2:17]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 50 °C
Procedure
To a stirred solution of 5-cyclohexyl-1,3-dihydro-1-methyl-3(R,S)-[(4-nitrophenyloxycarbonyl)amino]-2H-1,4-benzodiazepin-2-one (150 mg, 0.34 mmol) [Example 11, Step 3], in anhydrous dimethylformamide (3 ml) was added triethylamine (48 μl, 0.34 mmol). After 5 min a solution of 5-(3-aminophenyl)-2methyltetrazole (65 mg, 0.37 mmol) in anhydrous dimethylformamide (3m]) was added, and the solution heated at 50° C. for 2 h. After this time the solution was cooled to ambient temperature and evaporated in vacuo. The residue was dissolved in ethyl acetate (5 ml) and on standing a solid precipitated. This was recrystallised from ethyl acetate to afford the urea (65 mg, 40%) as a colourless solid. mp 195°-196° C. 1H NMR (360 MHz, CDCl3) δ 1.05-2.06 (10H, m), 2.79 (1H, m), 3.45 (3H, s), 4.36 (3H, s), 5.42 (1H, d, J=8 Hz), 6.75 (1H, d, J=8 Hz), 7.15-7.60 (7H, m), 7.77 (1H, d, J=8 Hz), 8.06 (1H, s).
Workup
- temperatureAfter this time the solution was cooled to ambient temperature
- customevaporated in vacuo
- dissolutionThe residue was dissolved in ethyl acetate (5 ml)
- customprecipitated
- customThis was recrystallised from ethyl acetate
Sources & evidence
- ORD record
- ord-4519e37285ad4b188a5a1a8437f4951b
- Source dataset
- uspto-grants-1994_11
- Patent number
- US05360802
Reaction notes
Loading…